Kaplan-Meier analysis revealed that patients with high PECAM1 expression had significantly worse prognosis than those with low expression (p = 0.003; HR = 5.05, 95% CI: 1.71–14.9) (Fig. S2F), supporting the link between CD31 and aggressive tumor behavior. This evidence concerns the gene PECAM1 and neoplasm.